March 20, 2014 | Israeli firm BioLight Israeli Life Sciences Investments, which invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, has announces the successful completion of a NIS 14.5 million (approx. $4.2 million) private placement. The investment was made by two unnamed institutional investors.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments